Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 R1 RCM RCM Mar 20, 2023 13.65 +3.57   
 Ra Medical Systems RMED Mar 20, 2023 1.60 -5.33   
 Rackspace Technology RXT Mar 20, 2023 1.75 -8.85   
 RADA Electronic Industries RADA Mar 20, 2023 9.87 0.00   
 Radcom RDCM Mar 20, 2023 10.03 -3.61   
 Radian Group RDN Mar 20, 2023 20.93 +2.75   
 Radiant Logistics RLGT Mar 20, 2023 5.21 -1.88   
 Radius Global Infrastructure RADI Mar 20, 2023 14.50 +0.42   
 RadNet RDNT Mar 20, 2023 23.74 +1.02   
 Radware RDWR Mar 20, 2023 20.16 -0.84   
 Rafael B RFL Mar 20, 2023 1.61 -7.47   
 Rail Vision RVSN Mar 20, 2023 1.46 +1.60   
 Rain Therapeutics RAIN Mar 20, 2023 7.77 -0.89   
 Rallybio RLYB Mar 20, 2023 4.55 -0.87   
 Ralph Lauren RL Mar 20, 2023 112.06 +1.03   
 Ramaco Resources METC Mar 20, 2023 8.38 -1.30   
 Rambus RMBS Mar 20, 2023 44.74 +1.50   
 Rand Capital RAND Mar 20, 2023 13.70 -3.14   
 Randolph Bancorp RNDB Mar 20, 2023 26.99 0.00   
 Range Resources Corp RRC Mar 20, 2023 23.33 +1.97   
 Ranger Energy Services A RNGR Mar 20, 2023 9.68 -1.93   
 Rani Therapeutics A RANI Mar 20, 2023 6.33 +0.16   
 Ranpak A PACK Mar 20, 2023 5.07 +0.60   
 Rapid Micro Biosystems A RPID Mar 20, 2023 1.27 -11.81   
 Rapid7 RPD Mar 20, 2023 39.37 +1.52   
 RAPT Therapeutics RAPT Mar 20, 2023 19.42 +2.53   
 Rare Earth/Str Metals ETF Market Vectors REMX Mar 20, 2023 75.57 +1.14   
 Rave Restaurant Group RAVE Mar 20, 2023 1.45 -4.61   
 Raymond James Financial RJF Mar 20, 2023 91.88 +4.39   
 Raymond James Financial A RJF-A Mar 20, 2023 24.92 +0.08   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+